To address radiation concerns by interventionalists and to help speed workflows in cath labs, Shimadzu released new AI features and single button push features for table and C-arm movement. 

A new study in the Journal of Nuclear Medicine offers insight into how the condition affects the general population, as well as how radiologists can help in the cardiac amyloidosis diagnostic journey.

The FDA is reclassifying interventional cardiovascular implant simulation software into the class II (special controls) regulatory category, which will make it easier for the technology to pass regulatory approval. 

A comparative analysis of health records found lower risks of documented COVID-19 infections after a third dose of Moderna, among other findings.

Cancer patients who are offered free hospital-provided rideshare services are more likely to comply with radiation therapy recommendations. 

A new clinical trial in Australia is one of the largest in the world to use brain imaging to test the impact of psychedelics on neural activity.

Buffalo Bills safety Damar Hamlin went into cardiac arrest after a tackle during the first quarter of a game with the Cincinnati Bengals on Jan 2.

Read our monthly recap of some of the biggest FDA-related stories that have hit cardiology, including updates related to Cytokinetics, Dexcom and Abiomed.